Cargando…

Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome

BACKGROUND: Insulin resistance is an integral component of a multi-organ dysfunction syndrome (MODS) associated with increased mortality. We determined a cutoff value for the homeostatic model assessment of insulin resistance (HOMA-IR) during an ICU admission that could predict 28-day mortality of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sama, Sonu, Jain, Gaurav, Kant, Ravi, Bhadoria, Ajeet S, Naithani, Manisha, Kumar, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693111/
https://www.ncbi.nlm.nih.gov/pubmed/35027795
http://dx.doi.org/10.5005/jp-journals-10071-24043
_version_ 1784619076905074688
author Sama, Sonu
Jain, Gaurav
Kant, Ravi
Bhadoria, Ajeet S
Naithani, Manisha
Kumar, Ajit
author_facet Sama, Sonu
Jain, Gaurav
Kant, Ravi
Bhadoria, Ajeet S
Naithani, Manisha
Kumar, Ajit
author_sort Sama, Sonu
collection PubMed
description BACKGROUND: Insulin resistance is an integral component of a multi-organ dysfunction syndrome (MODS) associated with increased mortality. We determined a cutoff value for the homeostatic model assessment of insulin resistance (HOMA-IR) during an ICU admission that could predict 28-day mortality of nondiabetic MODS patients. MATERIALS AND METHODS: In this prospective, outcome assessor blinded cohort design, we evaluated 82 such patients for fasting blood glucose (FBG)/insulin levels (FIL) during an ICU admission and followed their outcome for 28 days. The primary outcome variable was the HOMA-IR score calculated from the above variables. The statistical tool included receiver operating characteristic curve, Youden index, and correlation and regression analysis. RESULTS: Overall, 38 patients succumbed to their illness. The optimal cutoff value for HOMA-IR was ≥1.61 (area under curve: 0.684, sensitivity: 36.8%, specificity: 95.5%). The 28-day survival was significantly lower (p = 0.001) at HOMA-IR threshold ≥1.61 (odds ratio: 12.25, hazard ratio: 2.98). The mean HOMA-IR among survivors vs nonsurvivors was 0.76 ± 0.61 and 1.38 ± 1.14, respectively (p = 0.004). Except for FIL and FBG, HOMA-IR values did not correlate with any other baseline or outcome parameters (demographics, APACHE II/sequential organ failure assessment score, vasopressor needs, or ICU/hospital stay). On comparing these parameters across the HOMA-IR threshold, only FIL and the hospital stay varied significantly. Most of the outcome parameters, however, varied significantly among nonsurvivors vs survivors. CONCLUSION: The HOMA-IR is a significant predictor of mortality in MODS. Its cutoff value may assist in determining a reference range for critically ill patients. Its routine use in the light of other disease severity scores may serve in their better prognostication. HOW TO CITE THIS ARTICLE: Sama S, Jain G, Kant R, Bhadoria AS, Naithani M, Kumar A. Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome. Indian J Crit Care Med 2021;25(12):1364–1369.
format Online
Article
Text
id pubmed-8693111
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-86931112022-01-12 Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome Sama, Sonu Jain, Gaurav Kant, Ravi Bhadoria, Ajeet S Naithani, Manisha Kumar, Ajit Indian J Crit Care Med Original Article BACKGROUND: Insulin resistance is an integral component of a multi-organ dysfunction syndrome (MODS) associated with increased mortality. We determined a cutoff value for the homeostatic model assessment of insulin resistance (HOMA-IR) during an ICU admission that could predict 28-day mortality of nondiabetic MODS patients. MATERIALS AND METHODS: In this prospective, outcome assessor blinded cohort design, we evaluated 82 such patients for fasting blood glucose (FBG)/insulin levels (FIL) during an ICU admission and followed their outcome for 28 days. The primary outcome variable was the HOMA-IR score calculated from the above variables. The statistical tool included receiver operating characteristic curve, Youden index, and correlation and regression analysis. RESULTS: Overall, 38 patients succumbed to their illness. The optimal cutoff value for HOMA-IR was ≥1.61 (area under curve: 0.684, sensitivity: 36.8%, specificity: 95.5%). The 28-day survival was significantly lower (p = 0.001) at HOMA-IR threshold ≥1.61 (odds ratio: 12.25, hazard ratio: 2.98). The mean HOMA-IR among survivors vs nonsurvivors was 0.76 ± 0.61 and 1.38 ± 1.14, respectively (p = 0.004). Except for FIL and FBG, HOMA-IR values did not correlate with any other baseline or outcome parameters (demographics, APACHE II/sequential organ failure assessment score, vasopressor needs, or ICU/hospital stay). On comparing these parameters across the HOMA-IR threshold, only FIL and the hospital stay varied significantly. Most of the outcome parameters, however, varied significantly among nonsurvivors vs survivors. CONCLUSION: The HOMA-IR is a significant predictor of mortality in MODS. Its cutoff value may assist in determining a reference range for critically ill patients. Its routine use in the light of other disease severity scores may serve in their better prognostication. HOW TO CITE THIS ARTICLE: Sama S, Jain G, Kant R, Bhadoria AS, Naithani M, Kumar A. Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome. Indian J Crit Care Med 2021;25(12):1364–1369. Jaypee Brothers Medical Publishers 2021-12 /pmc/articles/PMC8693111/ /pubmed/35027795 http://dx.doi.org/10.5005/jp-journals-10071-24043 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Sama, Sonu
Jain, Gaurav
Kant, Ravi
Bhadoria, Ajeet S
Naithani, Manisha
Kumar, Ajit
Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title_full Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title_fullStr Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title_full_unstemmed Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title_short Quantifying the Homeostatic Model Assessment of Insulin Resistance to Predict Mortality in Multi-organ Dysfunction Syndrome
title_sort quantifying the homeostatic model assessment of insulin resistance to predict mortality in multi-organ dysfunction syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693111/
https://www.ncbi.nlm.nih.gov/pubmed/35027795
http://dx.doi.org/10.5005/jp-journals-10071-24043
work_keys_str_mv AT samasonu quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome
AT jaingaurav quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome
AT kantravi quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome
AT bhadoriaajeets quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome
AT naithanimanisha quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome
AT kumarajit quantifyingthehomeostaticmodelassessmentofinsulinresistancetopredictmortalityinmultiorgandysfunctionsyndrome